23 results on '"Wang, Eunice S."'
Search Results
2. Gemtuzumab ozogamicin plus standard induction chemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia
3. KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress
4. A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes
5. Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
6. Germline variants drive myelodysplastic syndrome in young adults
7. Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
8. Emerging trends of therapy related myeloid neoplasms following modern cancer therapeutics in the United States
9. A precision medicine classification for treatment of acute myeloid leukemia in older patients
10. A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
11. Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically
12. Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA
13. Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia
14. NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome
15. Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies
16. Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells
17. Adjustment to Acute Leukemia: The Impact of Social Support and Marital Satisfaction on Distress and Quality of Life Among Newly Diagnosed Patients and Their Caregivers
18. Development of a Preclinical PK/PD Model to Assess Antitumor Response of a Sequential Aflibercept and Doxorubicin-Dosing Strategy in Acute Myeloid Leukemia
19. Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
20. Is obesity a prognostic factor for acute myeloid leukemia outcome?
21. Can decreasing smoking prevalence reduce leukemia mortality?
22. Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies
23. Long-term response of refractory primary cold agglutinin disease to eculizumab therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.